Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

All MBC

• • A Personalized Medicine Study for Patients With Metastatic Breast Cancer (SMMART, Basket Study)
  • FPA150 and Pembrolizumab for Advanced Breast Cancer
  • LY3381916 Alone or With LY3300054 in Metastatic Breast Cancer

Triple-Negative

• • ABBV-927 and ABBV-368 for Advanced Triple Negative Breast Cancer
  • Avelumab With Binimetinib, Utomilumab, or PF-04518600 For Advanced Triple Negative Breast Cancer
  • Capivasertib & Paclitaxel as First-Line Treatment for Advanced Triple Negative Tumors
  • Estradiol in Advanced Triple Negative Tumors that Test Positive for ER Beta
  • Immunotherapy INCAGN02385 in Advanced Triple Negative Breast Cancer
  • Immunotherapy DKY709 Alone or With PDR001 in Advanced Triple Negative Breast Cancer
  • LY3023414 Followed by Prexasertib in Metastatic Triple Negative Breast Cancer
  • TPST-1120 Alone or With a Systemic Therapy in Advanced Triple Negative Breast Cancer
  • TT-00420 For Advanced Triple Negative Breast Cancer

HER2 Positive (HER2+)

• • T-DM1 and Tucatinib for Advanced HER2+ Breast Cancer

Others

• • Satoreotide Trizoxetan PET/CT and Satoreotide Tetraxetan in SSTR2+ Advanced Breast Cancer
  • Hyperthermia and Olaparib for Breast Cancer That Has Come Back in the Chest Wall

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.

Last Modified on August 25, 2020